Related Experiment Video
Updated: May 17, 2026

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
[Use of drug-eluting balloons for coronary interventions: current indications and perspectives]
1Unité d'hémodynamique diagnostique et interventionnelle, Institut Lorrain du coeur et des vaisseaux Louis-Mathieu, hôpitaux de Brabois, CHU de Nancy, allée du Morvan, 54511 Vandoeuvre-lès-Nancy, France. m.angioi@chu-nancy.fr
Abstract:
The paclitaxel-eluting balloon is an emerging percutaneous coronary angioplasty tool which aim is to prevent restenosis by delivering a high intravessel paclitaxel dose during balloon inflation. It has been already approved in the treatment of bare metal stent restenosis and is being investigated in drug-eluting stent restenosis. For the treatment of de novo lesions, it could be used alone or in combination with bare metal stent implantation. Most interesting results were obtained by a drug-eluting balloon alone strategy in small vessels angioplasty. Current and upcoming results of this evolving technology are reviewed.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease III: Interprofessional Care
